136 related articles for article (PubMed ID: 184053)
1. Analysis and modification of opiate reinforcement.
Meyer RE; McNamee HB; Mirin SM; Altman JL
Int J Addict; 1976; 11(3):467-84. PubMed ID: 184053
[TBL] [Abstract][Full Text] [Related]
2. Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study.
Altman JL; Meyer RE; Mirin SM; McNamee HB
Int J Addict; 1976; 11(3):485-99. PubMed ID: 184054
[TBL] [Abstract][Full Text] [Related]
3. A behavioral paradigm for the evaluation of narcotic antagonists.
Meyer RE; Mirin SM; Altman JL; McNamee HB
Arch Gen Psychiatry; 1976 Mar; 33(3):371-7. PubMed ID: 944026
[TBL] [Abstract][Full Text] [Related]
4. The clinical usefulness of narcotic antagonists: implications of behavioral research.
Meyer RE; Mirin SM; Altman JL
Am J Drug Alcohol Abuse; 1975; 2(3-4):417-32. PubMed ID: 179316
[No Abstract] [Full Text] [Related]
5. Aftercare on narcotic antagonists: prospects and problems.
Rawlins M; Randall M
Int J Addict; 1976; 11(3):501-11. PubMed ID: 184055
[TBL] [Abstract][Full Text] [Related]
6. Methadone maintenance and narcotic blocking drugs.
Wikler A
Int J Addict; 1977 Oct; 12(7):851-6. PubMed ID: 201577
[TBL] [Abstract][Full Text] [Related]
7. Methadone maintenance and narcotic blocking drugs. Appendix.
Wikler A
Int J Addict; 1977 Oct; 12(7):869-81. PubMed ID: 338517
[TBL] [Abstract][Full Text] [Related]
8. NIDA's naltrexone research program.
Julius D
NIDA Res Monogr; 1976 Sep; (9):5-11. PubMed ID: 187943
[No Abstract] [Full Text] [Related]
9. Predictors of retention in naltrexone maintenance for opioid dependence: analysis of a stage I trial.
Sullivan MA; Rothenberg JL; Vosburg SK; Church SH; Feldman SJ; Epstein EM; Kleber HD; Nunes EV
Am J Addict; 2006; 15(2):150-9. PubMed ID: 16595353
[TBL] [Abstract][Full Text] [Related]
10. Analysis and modification of opiate reinforcement. Discussion.
Meyer RE
Int J Addict; 1976; 11(3):545-9. PubMed ID: 965129
[No Abstract] [Full Text] [Related]
11. Narcotic antagonists: naltrexone progress report: foreword.
Jaffe J
NIDA Res Monogr; 1976 Sep; (9):v-vii. PubMed ID: 1088898
[No Abstract] [Full Text] [Related]
12. [The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts].
Yang G; Zhou W; Xu K
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):679-82. PubMed ID: 11715458
[TBL] [Abstract][Full Text] [Related]
13. The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone.
Lewis DC
Am J Drug Alcohol Abuse; 1975; 2(3-4):403-15. PubMed ID: 1227300
[No Abstract] [Full Text] [Related]
14. Narcotic antagonists in the treatment of opioid dependence: review and commentary.
Resnick RB; Schuyten-Resnick E; Washton AM
Compr Psychiatry; 1979; 20(2):116-25. PubMed ID: 421447
[No Abstract] [Full Text] [Related]
15. Limitations of an extinction approach to narcotic antagonist treatment.
Meyer R; Randall R; Barrington C; Mirin S; Greenberg I
NIDA Res Monogr; 1976 Sep; (9):123-35. PubMed ID: 187940
[No Abstract] [Full Text] [Related]
16. The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
Kleber H; Kinsella JK; Riordan C; Greaves S; Sweeney D
Arch Gen Psychiatry; 1974 Jan; 30(1):37-42. PubMed ID: 4808735
[No Abstract] [Full Text] [Related]
17. A behavioral intervention for improving verbal behaviors of heroin addicts in a treatment clinic.
Petry NM; Bickel WK; Tzanis E; Taylor R; Kubik E; Foster M; Hughes ME
J Appl Behav Anal; 1998; 31(2):291-7. PubMed ID: 9652105
[TBL] [Abstract][Full Text] [Related]
18. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
Rawson RA; Tennant FS
NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
[TBL] [Abstract][Full Text] [Related]
19. Treatment of heroin-dependent persons with antagonists: current status.
Renault PF
NIDA Res Monogr; 1981; 28():11-22. PubMed ID: 6791000
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
[Next] [New Search]
